CStone Pharmaceuticals (HKG:2616)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.34
-0.05 (-0.84%)
Sep 18, 2026, 4:08 PM HKT

CStone Pharmaceuticals Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
425.23269.58407.21463.84481.36243.72
Revenue Growth
57.74%-33.80%-12.21%-3.64%97.51%-76.54%
Gross Profit
238.2451.25240.15304.3278.38136.89
Operating Income
-375.22-415.83-95.36-579.16-912.15-1,829
Net Income
-419.1-437-91.21-367.23-902.68-1,920
Earnings Per Share
-0.28-0.31-0.07-0.29-0.77-1.65
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Mainland China
245.4583.84293.36370.23
Outside Mainland China
179.79185.74113.8593.61
Total
425.23269.58407.21463.84

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,626962.49719.881,0491,1481,779
Total Debt
357.24348.52355.97363.45286.29174.2
Net Cash (Debt)
1,269613.97363.91685.07861.311,604
Net Cash Growth
106.67%68.72%-46.88%-20.46%-46.32%-54.00%
Net Cash Per Share
0.850.440.290.540.731.38

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--327.75-303.21-588.84-610.74-1,484
Capital Expenditures
----0.02--91.03
Free Cash Flow
--327.75-303.21-588.86-610.74-1,575
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.03%19.01%58.98%65.60%57.83%56.17%
Operating Margin
-88.24%-154.25%-23.42%-124.86%-189.49%-750.64%
Pretax Margin
-95.49%-157.26%-22.40%-79.17%-187.53%-787.84%
Profit Margin
-98.56%-162.10%-22.40%-79.17%-187.53%-787.84%
FCF Margin
--121.58%-74.46%-126.95%-126.88%-646.26%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
29.7314.08----
PS Ratio
17.3225.896.785.6710.1432.19